Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry
- 9 May 2013
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 112 (2) , 182-189
Abstract
Objective: To investigate causes of death in a UK cohort of patients with prostate cancer. Patients and Methods: We examined causes of death in a UK cohort of 50 066 men with prostate cancer diagnosed between 1997 and 2006 reported to the T hames C ancer R egistry ( TCR ) and followed‐up to the end of 2007. The underlying cause of death was taken from the death certificate. Uptake of PSA screening was low in the UK during the period studied. We examined the relationship between cause of death and patient characteristics at diagnosis including age, cancer stage, and treatment (≤6 months of diagnosis). Results: In all, 20 181 deaths occurred during the period; 49.8% recorded as being due to prostate cancer, 17·8% to cardiovascular disease, 11·6% to other cancers, and 20·7% to other causes. Irrespective of age, cancer stage, or treatment ≤6 months of diagnosis, prostate cancer was an important cause of death ranging from 31·6% to 74·3% of all deaths in different subgroups. Conclusion: For men with prostate cancer diagnosed in a setting where uptake of PSA screening is low, our findings challenge the belief that prostate cancer is not an important cause of death.Keywords
This publication has 14 references indexed in Scilit:
- Prostate‐specific antigen testing rates remain low in UK general practice: a cross‐sectional study in six English citiesBJU International, 2011
- A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006European Urology, 2011
- Population‐based prostate‐specific antigen testing in the UK leads to a stage migration of prostate cancerBJU International, 2009
- Outcomes of Localized Prostate Cancer Following Conservative ManagementJAMA, 2009
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005JNCI: Journal of the National Cancer Institute, 2009
- Rates of prostate‐specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross‐sectional studyBJU International, 2004
- Determining Cause of Death in Prostate Cancer: Are Death Certificates Valid?JNCI: Journal of the National Cancer Institute, 2001
- Rising incidence of prostate cancer in Scotland: increased risk or increased detection?BJU International, 2000
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989